Brachytherapy
Volume 8, Issue 4 , Pages 339-344 , October 2009

High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience

  • Siavash Jabbari

      Affiliations

    • Department of Radiation Oncology, University of California San Francisco, San Francisco, CA
    • ,
  • I.-Chow Hsu

      Affiliations

    • Department of Radiation Oncology, University of California San Francisco, San Francisco, CA
    • ,
  • Jun Kawakami

      Affiliations

    • Department of Urology, University of California San Francisco, San Francisco, CA
    • ,
  • Vivian K. Weinberg

      Affiliations

    • Department of Biostatistics, University of California San Francisco, San Francisco, CA
    • ,
  • Joycelyn L. Speight

      Affiliations

    • Department of Radiation Oncology, University of California San Francisco, San Francisco, CA
    • Department of Urology, University of California San Francisco, San Francisco, CA
    • ,
  • Alexander R. Gottschalk

      Affiliations

    • Department of Radiation Oncology, University of California San Francisco, San Francisco, CA
    • ,
  • Mack Roach III

      Affiliations

    • Department of Radiation Oncology, University of California San Francisco, San Francisco, CA
    • Department of Urology, University of California San Francisco, San Francisco, CA
    • ,
  • Katsuto Shinohara

      Affiliations

    • Department of Urology, University of California San Francisco, San Francisco, CA
    • Corresponding Author InformationCorresponding author. Department of Urology, University of California San Francisco, 1600 Divisadero Avenue, MZ Bldg A, Room A-643, San Francisco, CA 94115. Tel.: +1-415-353-7101; fax: +1-415-353-7443.

Received 21 November 2008 ,Revised 11 February 2009 ,Accepted 13 February 2009.

References 

  1. Society AC . Estimated new cancer cases and deaths by sex for all sites, US, 2007. Atlanta: American Cancer Society; 2007;
  2. Moot AR, Polglase A, Giles GG, et al. Men with colorectal cancer are predisposed to prostate cancer. ANZ J Surg. 2003;73:289–293
  3. Murray SK, Breau RH, Guha AK, et al. Spread of prostate carcinoma to the perirectal lymph node basin: Analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma. Am J Surg Pathol. 2004;28:1154–1162
  4. Engstrom PF, Benson AB, Chen YJ, et al. Rectal cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2005;3:492–508
  5. Shinohara K, Gulati M, Koppie TM, et al. Transperineal prostate biopsy after abdominoperineal resection. J Urol. 2003;169:141–144
  6. Koutrouvelis PG, Theodorescu D, Katz S, et al. Brachytherapy of prostate cancer after colectomy for colorectal cancer: Pilot experience. J Urol. 2005;173:82–85discussion 85–6
  7. Kim Y, Hsu I-C, Pouliot J. Measurement of craniocaudal catheter displacement between fractions in computed tomography-based high dose rate brachytherapy of prostate cancer. J Appl Clin Med Phys. 2007;8:1–13
  8. Holloway C, Hsu I-C, Albert M, et al. Prostate brachytherapy. In:  Devlin P editors. Brachytherapy applications and techniques. Philadelphia: Lippincott Williams and Wilkins Company; 2007;
  9. Lee B, Shinohara K, Weinberg V, et al. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: The University of California-San Francisco experience. Int J Radiat Oncol Biol Phys. 2007;67:1106–1112
  10. Hsu IC, Cabrera AR, Weinberg V, et al. Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer. Brachytherapy. 2005;4:202–206
  11. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys. 1997;37:1035–1041
  12. Roach M, Hanks G, Thames H, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006;65:965–974
  13. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13:176–181
  14. Vargas C, Martinez A, Galalae R, et al. High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features. Prostate Cancer Prostatic Dis. 2006;9:245–253
  15. Niehoff P, Loch T, Nurnberg N, et al. Feasibility and preliminary outcome of salvage combined HDR brachytherapy and external beam radiotherapy (EBRT) for local recurrences after radical prostatectomy. Brachytherapy. 2005;4:141–145
  16. Grills IS, Martinez AA, Hollander M, et al. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol. 2004;171:1098–1104
  17. Martinez AA, Pataki I, Edmundson G, et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report. Int J Radiat Oncol Biol Phys. 2001;49:61–69
  18. Mullokandov E, Gejerman G. Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy. Int J Radiat Oncol Biol Phys. 2004;58:1063–1071
  19. Hoskin PJ, Bownes PJ, Ostler P, et al. High dose rate afterloading brachytherapy for prostate cancer: Catheter and gland movement between fractions. Radiother Oncol. 2003;68:285–288
  20. Damore SJ, Syed AM, Puthawala AA, et al. Needle displacement during HDR brachytherapy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2000;46:1205–1211
  21. Van Gellekom MP, Moerland MA, Battermann JJ, et al. MRI-guided prostate brachytherapy with single needle method—A planning study. Radiother Oncol. 2004;71:327–332
  22. Cormack RA, Kooy H, Tempany CM, et al. A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2000;46:207–214

 This article represents original work not previously published, and will not be submitted elsewhere while under consideration by Brachytherapy.

 Conflict of interest/financial disclosure: Katsuto Shinohara is a consultant for Nihon Mediphysics Co. Ltd.

PII: S1538-4721(09)00200-1

doi: 10.1016/j.brachy.2009.02.004

Brachytherapy
Volume 8, Issue 4 , Pages 339-344 , October 2009

Article Tools

* Image Usage & Resolution